These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11326198)

  • 21. Gamma-hydroxybutyrate dependence with social phobia.
    Trendelenburg G; Heinz A; Ströhle A
    Am J Psychiatry; 2004 Feb; 161(2):375-6. PubMed ID: 14754796
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
    Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
    CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comment on "The abrupt cessation of therapeutically administered sodium oxybate (GHB) may cause withdrawal symptoms".
    Zvosec DL; Smith SW
    J Toxicol Clin Toxicol; 2004; 42(1):121-3; author reply 125-7. PubMed ID: 15083950
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical management of gamma-hydroxybutyrate (GHB) withdrawal delirium with CIWA-Ar protocol.
    Liao PC; Chang HM; Chen LY
    J Formos Med Assoc; 2018 Dec; 117(12):1124-1127. PubMed ID: 29933901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Withdrawal syndromes.
    Olmedo R; Hoffman RS
    Emerg Med Clin North Am; 2000 May; 18(2):273-88. PubMed ID: 10767884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Life threatening symptoms of withdrawal of gamma-hydroxybutyrate].
    Veerman SR; Dijkstra HN; Liefting-Kluft I
    Tijdschr Psychiatr; 2010; 52(6):411-6. PubMed ID: 20544599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inpatient management of gamma-hydroxybutyrate withdrawal.
    Cappetta M; Murnion BP
    Australas Psychiatry; 2019 Jun; 27(3):284-287. PubMed ID: 30652947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two cases of withdrawal from 1,4-Butanediol use.
    Mycyk MB; Wilemon C; Aks SE
    Ann Emerg Med; 2001 Sep; 38(3):345-6. PubMed ID: 11524661
    [No Abstract]   [Full Text] [Related]  

  • 29. Lack of efficacy of benzodiazepines in treating gamma-hydroxybutyrate withdrawal.
    Mullins ME; Fitzmaurice SC
    J Emerg Med; 2001 May; 20(4):418-20. PubMed ID: 11396429
    [No Abstract]   [Full Text] [Related]  

  • 30. Inpatient Gamma-Hydroxybutyrate Detoxification: A Case Report Describing Day-to-day Therapeutic Management.
    von Theobald L; Rousselet M; Cholet J; Debar H; Boels D; Victorri-Vigneau C; Grall-Bronnec M
    J Addict Med; 2017; 11(3):231-234. PubMed ID: 28125446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary web-based measures development for GHB: expectancies, functions, and withdrawal.
    Stein LA; Lebeau R; Clair M; Martin R; Bryant M; Storti S
    Am J Drug Alcohol Abuse; 2012 Mar; 38(2):121-9. PubMed ID: 22175869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenmetrazine psychoses.
    Jaroszyński J; Spasowicz E; Ulasińska-Rubach D
    Pol Med J; 1971; 10(1):253-7. PubMed ID: 5573909
    [No Abstract]   [Full Text] [Related]  

  • 33. Epileptic seizure in GHB withdrawal.
    Chew G; Fernando A
    Australas Psychiatry; 2004 Dec; 12(4):410-1. PubMed ID: 15715821
    [No Abstract]   [Full Text] [Related]  

  • 34. Two cases of severe gamma-hydroxybutyrate withdrawal delirium on a psychiatric unit: recommendations for management.
    Rosenberg MH; Deerfield LJ; Baruch EM
    Am J Drug Alcohol Abuse; 2003 May; 29(2):487-96. PubMed ID: 12765217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gamma-hydroxybutyrate--an endogenous substance and an intoxicant].
    Hovda KE; Liberg JP; Nordby G; Jacobsen D
    Tidsskr Nor Laegeforen; 1998 Nov; 118(28):4390-3. PubMed ID: 9889613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-patient detoxification after GHB dependence.
    Price G
    Br J Psychiatry; 2000 Aug; 177():181. PubMed ID: 11026962
    [No Abstract]   [Full Text] [Related]  

  • 37. Alprazolam withdrawal insomnia.
    Slak S
    Psychol Rep; 1986 Apr; 58(2):343-6. PubMed ID: 2871575
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of gamma-hydroxybutyrate withdrawal].
    Strand NAW; Petersen TS; Nielsen LM; Boegevig S
    Ugeskr Laeger; 2017 Dec; 179(50):. PubMed ID: 29260701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence.
    Mannucci C; Pichini S; Spagnolo EV; Calapai F; Gangemi S; Navarra M; Calapai G
    Curr Drug Metab; 2018; 19(13):1056-1064. PubMed ID: 29219048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known.
    van Noorden MS; van Dongen LC; Zitman FG; Vergouwen TA
    Gen Hosp Psychiatry; 2009; 31(4):394-6. PubMed ID: 19555805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.